1607590-84-0

Basic information

• Product Name: tert-butyl (3-formylcyclohexyl)carbamate
• Synonyms: tert-butyl (3-formylcyclohexyl)carbamate
• CAS NO: 1607590-84-0
• Molecular Weight: 227.304
• Mol File: 1607590-84-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: tert-butyl (3-formylcyclohexyl)carbamate(CAS DataBase Reference)
• NIST Chemistry Reference: tert-butyl (3-formylcyclohexyl)carbamate(1607590-84-0)
• EPA Substance Registry System: tert-butyl (3-formylcyclohexyl)carbamate(1607590-84-0)

Safety Data

• Hazardous Substances Data: 1607590-84-0(Hazardous Substances Data)

Upstream product

• 16636-51-4 3-aminocyclohexanecarboxylic acid 
• 24424-99-5 di-tert-butyl dicarbonate 
• 406212-45-1 tert-butyl 3-(methoxy(methyl)carbamoyl)cyclohexylcarbamate 
• 920966-16-1 tert-butyl [3-(hydroxymethyl)cyclohexyl]carbamate 
• 334932-13-7 3-[(tert-butoxycarbonyl)amino]cyclo-hexanecarboxylic acid 

Downstream Products

• 1607590-85-1 tert-butyl {3-[2-cyanovinyl]cyclohexyl}carbamate 
• 1607590-86-2 3-(3-aminocyclohexyl)acrylonitrile hydrochloride 
• 1607590-87-3 3-{3-[(6-nitrothieno[3,2-b]pyridin-7-yl)amino]cyclohexyl}acrylonitrile 
• 1607590-88-4 3-{3-[(6-aminothieno[3,2-b]pyridin-7-yl)amino]cyclohexyl}propanenitrile 
• 1607590-83-9 3-(3-{2-[(1R)-1-hydroxyethyl]-1H-imidazo[4,5-d]thieno[3,2-b]pyridin-1-yl}cyclohexyl)propanenitrile 

Relevant articles and documents

ANTI-INFECTIVE HETEROCYCLIC COMPOUNDS AND USES THEREOF

The present invention relates to heterocyclic compounds of Formula I useful as anti-infective agents. The present invention further relates to a method of treating an infection by administering such compounds, and to pharmaceutical compositions comprising such compounds.

PYRROLO[2,3-B]PYRIDINE CDK9 KINASE INHIBITORS

Disclosed are compounds of Formula (IIa), wherein R1, R2, R3A, R3B, R3C, R3D, R3E, and R4 are as defined in the specification, and pharmaceutically acceptable salts thereof. The compounds may be used as agents in the treatment of diseases, including cancer. Also provided are pharmaceutical compositions comprising one or more compounds of Formula (IIa)